Dr. Whyte received a grant and served as a consultant for Enobia Pharma, Montreal, Canada. He owns stock in Merck.
Version of Record online: 29 DEC 2008
Copyright © 2009 ASBMR
Journal of Bone and Mineral Research
Volume 24, Issue 6, pages 1132–1134, June 2009
How to Cite
Whyte, M. P. (2009), Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia. J Bone Miner Res, 24: 1132–1134. doi: 10.1359/jbmr.081253
Published online on December 29, 2008
- Issue online: 4 DEC 2009
- Version of Record online: 29 DEC 2008
- Manuscript Accepted: 22 DEC 2008
- Manuscript Revised: 26 NOV 2008
- Manuscript Received: 30 SEP 2008
Lateral subtrochanteric femoral pseudofractures occurring in adults with osteomalacia from hypophosphatasia and X-linked hypophosphatemia support the hypothesis that atypical femoral fractures in osteoporosis treated with bisphosphonates also result from low bone turnover.